Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group

被引：0
|
作者：
C. I. Müller
K. Schulmann
A. Reinacher-Schick
N. Andre
D. Arnold
A. Tannapfel
H. Arkenau
S. A. Hahn
S. H.-J. Schmoll
R. Porschen
W. Schmiegel
U. Graeven
机构：
[1] University Hospital Essen,Institute of Physiology
[2] Ruhr-University of Bochum,Medical Department
[3] Martin Luther University,Medical Department IV, University Clinic
[4] Ruhr-University of Bochum,Institute of Pathology, University Clinic Bergmannsheil
[5] Royal Marsden Hospital and Institute of Cancer Research,Drug Development Unit
[6] Ruhr-University of Bochum,Center for Clinical Research (ZKF, Molecular GI
[7] Medical Department Klinikum Bremen-Ost,Oncology (MGO))
[8] Ruhr-University of Bochum,Division of Gastroenterology and Hepatology, University Hospital Bergmannsheil
[9] Kliniken Maria Hilf GmbH Klinik für Hämatologie,undefined
[10] Onkologie,undefined
[11] Gastroenterologie,undefined
来源：
International Journal of Colorectal Disease | 2008年 / 23卷
关键词：
Colorectal cancer; Microsatellite instability; Chemotherapy; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1033 / 1039
页数：6
相关论文
共 50 条
  • [41] Prognostic Factors for Colorectal Cancer Patients Treated With Combination of Immune-cell Therapy and First-line Chemotherapy: A Retrospective Study
    Takimoto, Rishu
    Kamigaki, Takashi
    Okada, Sachiko
    Matsuda, Eriko
    Ibe, Hiroshi
    Oguma, Eri
    Naitoh, Keiko
    Makita, Kaori
    Goto, Shigenori
    ANTICANCER RESEARCH, 2019, 39 (08) : 4525 - 4532
  • [42] Prognostic role of sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy: A retrospective study
    Maddalena, Chiara
    Ponsiglione, Andrea
    Camera, Luigi
    Santarpia, Lidia
    Pasanisi, Fabrizio
    Bruzzese, Dario
    Panico, Camilla
    Fiore, Giovanni
    Camardella, Simona
    Caramia, Tolomeo
    Farinaro, Alessia
    De Placido, Sabino
    Carlomagno, Chiara
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (05): : 355 - 366
  • [43] Handy prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer
    Chibaudel, B.
    Tournigand, C.
    Bonnetain, F.
    Andre, T.
    Lledo, G.
    Maindrault-Goebel, F.
    Larsen, A. K.
    Louvet, C.
    de Gramont, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] Irinotecan and mitomycin C (MMC) as salvage therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidine, irinotecan and/or oxaliplatin based chemotherapy.
    Rodriguez, I
    Viudez, A
    Salgado, E
    García-Foncillas, J
    De La Cámara, J
    Espinós, J
    Garrán, C
    Chopitea, A
    Fernández-Hidalgo, O
    Martín-Algarra, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 308S - 308S
  • [45] Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients
    Park, Hanla A.
    Edelmann, Dominic
    Canzian, Federico
    Seibold, Petra
    Harrison, Tabitha A.
    Hua, Xinwei
    Shi, Qian
    Silverman, Allison
    Benner, Axel
    Macauda, Angelica
    Schneider, Martin
    Goldberg, Richard M.
    Alberts, Steven R.
    Hoffmeister, Michael
    Brenner, Hermann
    Chan, Andrew T.
    Peters, Ulrike
    Newcomb, Polly A.
    Chang-Claude, Jenny
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (09) : 1623 - 1634
  • [46] The efficiency of FOLFOX and XELOX application as a first-line chemotherapy of the advanced colorectal cancer patients
    Zeynalov, R.
    Musayev, I
    Gasanzadeh, J.
    Ahadova, N.
    Dadasheva, N.
    ANNALS OF ONCOLOGY, 2006, 17 : 81 - 81
  • [47] Changes in first-line chemotherapy do not improve survival in patients with advanced colorectal cancer
    Carnaghi, C.
    Rimassa, L.
    Zuradelli, M.
    Morenghi, E.
    Torri, V
    Tronconi, M.
    Tondulli, L.
    Pressiani, T.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2006, 17 : 67 - 68
  • [48] Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study
    Chibaudel, Benoist
    Bonnetain, Franck
    Tournigand, Christophe
    Bengrine-Lefevre, Leila
    Teixeira, Luis
    Artru, Pascal
    Desrame, Jerome
    Larsen, Annette K.
    Andre, Thierry
    Louvet, Christophe
    de Gramont, Aimery
    ONCOLOGIST, 2011, 16 (09): : 1228 - 1238
  • [49] Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
    Pare, L.
    Marcuello, E.
    Altes, A.
    del Rio, E.
    Sedano, L.
    Salazar, J.
    Cortes, A.
    Barnadas, A.
    Baiget, M.
    BRITISH JOURNAL OF CANCER, 2008, 99 (07) : 1050 - 1055
  • [50] Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
    L Paré
    E Marcuello
    A Altés
    E del Río
    L Sedano
    J Salazar
    A Cortés
    A Barnadas
    M Baiget
    British Journal of Cancer, 2008, 99 : 1050 - 1055
12345